Herbal medicines and nutraceuticals for diabetic vascular complications: Mechanisms of action and bioactive phytochemicals

Current Pharmaceutical Design

Volumn 16, Issue 34, 2010, Pages 3776-3807

  Omara, Eshaifol A ^a   Kam, Antony ^a   Alqahtania, Ali ^a   Li, Kong M ^b   Razmovski Naumovski, Valentina ^a,d   Nammi, Srinivas ^a,c   Chan, Kelvin ^a,d   Roufogalis, Basil D ^a   Li, George Q ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF CANBERRA   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Anti oxidants; Diabetic complications; Herbal medicines; Inflammation; Mechanisms of action; Nutraceuticals; Phytochemicals

Indexed keywords

ASTILBIN; ASTRAGALOSIDE IV; BAICALEIN; BERBERINE; BREVISCAPINE; CURCUMIN; DELPHINIDIN; EPIGALLOCATECHIN GALLATE; EUGENOL; FISH OIL; GAMMA LINOLENIC ACID; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOLIQUIRITIGENIN; LITHOSPERMATE B; LITHOSPERMIC ACID B; MAGNOLOL; MALTOL; MANGIFERIN; NUTRACEUTICAL; OLEANOLIC ACID; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE 4; PROTOCATECHUALDEHYDE; PUERARIN; QUERCETIN; SAPONIN DERIVATIVE; SAPONIN I; THIOCTIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALFALFA; ALOE VERA; ANGELICA SINENSIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; CAPSICUM FRUTESCENS; CARDIOVASCULAR DISEASE; CENTELLA ASIATICA; CHINESE MEDICINE; CINNAMOMUM ZEYLANICUM; CINNAMONUM CASSIA; COCHRANE LIBRARY; COLOCASSIA ESCULENTA; CURCUMA LONGA; DIABETES MELLITUS; DIOSCOREA CAYENENSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG QUALITY; DRUG SAFETY; EUGENIA JAMBOLANA; EVENING PRIMROSE; FENUGREEK; GANODERMA LUCIDUM; GARLIC; GINGER; GINKGO BILOBA; GINSENG; GRAPE; GYMNEMA MONTANUM; GYNOSTEMMA PENTAPHYLLUM; HERBAL MEDICINE; HONEY; JUGLANS REGIA; LINSEED; LYCIUM BARBARUM; MEDICINAL PLANT; MEDLINE; MOMORDICA CHARANTIA; NONHUMAN; OLIVE TREE; PAEONIA SUFFRUTICOSA; PANAX NOTOGINSENG; PAPAYA; PINUS PINASTER; POLYGONATUM ODORATUM; POMEGRANATE; PRIORITY JOURNAL; PUERARIA LOBATA; REHMANNIA GLUTINOSA; RHEUM OFFICINALE; RHODIOLA ROSEA; SALVIA HISPANICA; SALVIA MILTIORRHIZA; SOYBEAN; SYZGIUM CUMINI; TEA; TINOSPORA CORDIFOLIA; VACCINIUM MYRTILLUS; VASCULITIS; WITHANIA SOMNIFERA;

DIABETES COMPLICATIONS; DIETARY SUPPLEMENTS; HERBAL MEDICINE; HUMANS; VASCULAR DISEASES;

EID: 79551643521     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210794455076     Document Type: Article

References (397)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (5): 1047-53.
2. WHO. Diabetes Action Now: An initiative of the world health organization and the international diabetes federation. Geneva: World Health Organization 2004.
3. IDF. Diabetes Atlas 3rd Ed. Brussels: International Diabetes Federation 2008.
4. Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009; 53 (5 Suppl): S35-42.
5. Hamik A, Atkins GB, Jain MK. Molecular mechanisms of diabetic vasculopathy. Drug Discov Today Dis Mech 2005; 2 (1): 11-7.
6. He Z, King GL. Microvascular complications of diabetes. Endocrinol Metab Clin North Am 2004; 33 (1): 215-38, xi-xii.
7. Fuller JH, Elford J, Goldblatt P, Adelstein AM. Diabetes mortality: new light on an underestimated public health problem. Diabetologia 1983, 24 (5): 336-41.
8. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl 2): S14-21.
9. WHO Diabetes. World Health Organization: November 2009.
10. Matthaei S, Stumvoll M, Kellerer M, Haring HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocr. Rev 2000; 21 (6): 585-618.
11. Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 2004; 92 (1): 1-21.
12. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a longterm follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999; 22 (1): 99-111.
13. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329 (14): 977-86.
14. Duckworth W, Abraira C, Moritz T, et al. Huang, G.D. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360 (2): 129-39.
15. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352 (16): 1685-95.
16. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116 (7): 1793-801.
17. Galkina E, Ley K. Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy. J Am Soc Nephrol 2006; 17 (2): 368-77.
18. Chibber R, Ben-Mahmud BM, Chibber S, Kohner EM. Leukocytes in Diabetic Retinopathy. Curr Diabetes Rev 2007; 3: 3-14.
19. Libby P. Inflammation in atherosclerosis. Nature 2002; 420 (6917): 868-74.
20. Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 2001; 107 (3): 255-64.
21. Bowie A, O'Neill LAJ. Oxidative stress and nuclear factor- [kappa]B activation: A reassessment of the evidence in the light of recent discoveries. BioChem Pharmacol 2000; 59 (1): 13-23.
22. Inoue I, Katayama S, Takahashi K, et al. Troglitazone has a scavenging effect on reactive oxygen species. BioChem Biophys Res Commun 2097; 235 (1): 113-16.
23. Cominacini L, Garbin U, Pasini AF, et al. The expression of adhesion molecules on endothelial cells is inhibited by troglitazone through its antioxidant activity. Cell Adhes Commun 1999; 7 (3): 223-31.
24. Peraldi P, Xu M, Spiegelman BM. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. J Clin Invest 1997; 100 (7): 1863-9.
25. Rajesh M, Mukhopadhyay P, Batkai S, et al. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol 2007; 293 (1): H610-9.
26. Nam NH. Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 2006; 6 (8): 945-951.
27. Weber C, Erl W, Pietsch A, et al. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994; 14 (10): 1665-73.
28. Tetsuka T, Baier LD, Morrison AR. Antioxidants Inhibit Interleukin-1-induced Cyclooxygenase and Nitric-oxide Synthase Expression in Rat Mesangial Cells J Biol Chem 1996; 271 (20): 11689-93.
29. Liang YZ, Xie P, Chan K. Quality control of herbal medicines. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 812 (1-2): 53-70.
30. Li GQ, Razmovski-Naumovski V, Omar E, et al. Evaluation of biological activity in quality control of herbal medicines. In: Gupta VK, Verma AK, Kaul S, Eds. Comprehensive Bioactive Natural Products - Quality Control & Standardization. USA: Studium Press 2010; Vol. 8: pp. 137-79.
31. Li GQ, Razmovski-Naumovski V, Omar E, et al. Comprehensive Bioactive Natural Products - Quality Control & Standardization. In: Gupta VK, Verma AK, Kaul S. Eds. USA: Studium Press 2010; Vol. 8: pp. 181-215.
32. Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 2010; 243 (2): 208-16.
33. Wang J, van der Heijden R, Spruit S, et al. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J Ethnopharmacol 2009; 126 (1): 31-41.
34. Therapeutic Goods Administration. Guidelines for Levels and Kinds of Evidence to Support Indications and Claims For Non- Registerable Medicines, including Complementary Medicines, and other Listable Medicines 2001.
35. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. http://www.nhmrc.gov.au/guidelines/developerSHtm (15 June 2010).
36. Loew D, Kaszkin M. Approaching the problem of bioequivalence of herbal medicinal products. Phytother Res 2002; 16 (8): 705-11.
37. Chan K. Progress in traditional Chinese medicine. Trends Pharmacol Sci 1995, 16 (6): 182-7.
38. Liu DS, Chen KZ, Zhang CL. Study on relationship between brain function and syndrome differentiation-typing of TCM in noninsulin dependent diabetes mellitus. Zhongguo Zhong Xi Yi Jie He Za Zhi 1994, 14 (8): 454-7.
39. Ceylan-Isik AF, Fliethman RM, Wold LE, Ren J. Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus. Curr Diabetes Rev 2008; 4 (4): 320-8.
40. Tang W, Eisenbrand G. Chinese drugs of plant origin: chemistry, pharmacology, and use in traditional and modern medicine. Berlin; New York: Springer-Verlag 1992.
41. Hui H, Tang G, Go VL. Hypoglycemic herbs and their action mechanisms. Chin Med 2009; 4, 11.
42. Liu JP, Zhang M, Wang WY, Grimsgaard S. Chinese herbal medicines for type 2 diabetes mellitus. Cochrane Database Syst Rev 2004 (3): CD003642.
43. Liao F. Herbs of activating blood circulation to remove blood stasis. Clin Hemorheol Microcirc 2000; 23 (2-4): 127-31.
44. Qin F, Huang X. Guanxin II (II) for the management of coronary heart disease. Chin J Integr Med 2009; 15 (6): 472-6.
45. Wang BH, Ou-Yang JP. Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc Drug Rev 2005; 23 (2): 161-72.
46. Huyen VT, Phan DV, Thang P, Hoa NK, Ostenson CG. Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients. Horm Metab Res 2010; 42 (5): 353-7.
47. Huang TH, Li Y, Razmovski-Naumovski V, et al. Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway. J Biomed Sci 2006; 13 (4): 535-48.
48. Huang TH, Tran VH, Roufogalis BD, Li Y. Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells. Toxicol Appl Pharmacol 2007; 218 (1): 30-6.
49. Huang TH, Tran VH, Roufogalis BD, Li Y. Gypenoside XLIX, a naturally occurring PPAR-alpha activator, inhibits cytokineinduced vascular cell adhesion molecule-1 expression and activity in human endothelial cells. Eur J Pharmacol 2007; 565 (1-3): 158-65.
50. Ge M, Ma S, Tao L, Guan S. The effect of gypenosides on cardiac function and expression of cytoskeletal genes of myocardium in diabetic cardiomyopathy rats. Am J Chin Med 2009; 37 (6): 1059-68.
51. Aktan F, Henness S, Roufogalis BD, Ammit AJ. Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-kappaB-mediated iNOS protein expression. Nitric oxide 2003; 8 (4): 235-42.
52. Megalli S, Davies NM, Roufogalis BD. Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat. J Pharm Pharm Sci 2006; 9 (3): 281-91.
53. Norberg A, Hoa NK, Liepinsh E, et al. A novel insulin-releasing substance, phanoside, from the plant Gynostemma pentaphyllum. J Biol Chem 2004; 279 (40): 41361-7.
54. Cheng TO. All teas are not created equal: the Chinese green tea and cardiovascular health. Int J Cardiol 2006; 108 (3): 301-8.
55. Braun L, Cohen M. Herbs and Natural Supplements: An Evidence- Based Guide. 3rd ed. Australia: Churchill Livingstone 2010.
56. Nicoll R, Henein MY. Ginger (Zingiber officinale Roscoe): a hot remedy for cardiovascular disease? Int J Cardiol 2009; 131 (3): 408-9.
57. Mariee AD, Abd-Allah GM, El-Yamany MF. Renal oxidative stress and nitric oxide production in streptozotocin-induced diabetic nephropathy in rats: the possible modulatory effects of garlic (Allium sativum L.). Biotechnol Appl Biochem 2009; 52 (Pt 3): 227-32.
58. Lee YM, Gweon OC, Seo YJ, et al. Antioxidant effect of garlic and aged black garlic in animal model of type 2 diabetes mellitus. Nutr Res Pract 2009; 3 (2): 156-61.
59. Patumraj S, Tewit S, Amatyakul S, et al. Comparative effects of garlic and aspirin on diabetic cardiovascular complications. Drug Deliv 2000; 7 (2): 91-6.
60. Prabjone R, Thong-Ngam D, Wisedopas N, Chatsuwan T, Patumraj S. Anti-inflammatory effects of Aloe vera on leukocyteendothelium interaction in the gastric microcirculation of Helicobacter pylori-infected rats. Clin Hemorheol Microcirc 2006;35 (3): 359-66.
61. Im SA, Lee YR, Lee YH, et al. In vivo evidence of the immunomodulatory activity of orally administered Aloe vera gel. Arch Pharm Res 2010; 33 (3): 451-6.
62. Rajasekaran S, Sivagnanam K, Subramanian S. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 2005; 57 (1): 90-6.
63. Rajasekaran S, Sivagnanam K, Subramanian S. Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin. J Pharm Pharmacol 2005; 57 (2): 241-6.
64. Bolkent S, Akev N, Ozsoy N, Sengezer-Inceli M, Can A, Alper O, Yanardag R. Effect of Aloe vera (L.) Burm. fil. leaf gel and pulp extracts on kidney in type-II diabetic rat models. Indian J Exp Biol 2004; 42 (1): 48-52.
65. Chithra P, Sajithlal GB, Chandrakasan G. Influence of aloe vera on the healing of dermal wounds in diabetic rats. J Ethnopharmacol 1998, 59 (3) 205-201.
66. Li R, Zhang J, Zhang L, Cui Q, Liu H. Angelica Injection Promotes Peripheral nerve structure and function recovery with increased expressions of nerve growth factor and brain derived neurotrophic factor in diabetic rats. Curr Neurovasc Res 2010; 7 (3): 213-22.
67. Liu ZQ, Li QZ, Qin GJ. Effect of Astragalus injection on platelet function and plasma endothelin in patients with early stage diabetic nephropathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001; 21 (4): 274-6.
68. Liu KZ, Li JB, Lu HL, Wen JK, Han M. [Effects of Astragalus and saponins of Panax notoginseng on MMP-9 in patients with type 2 diabetic macroangiopathy]. Zhongguo Zhong Yao Za Zhi 2004; 29 (3): 264-6.
69. Chen W, Li YM, Yu MH. Astragalus polysaccharides: an effective treatment for diabetes prevention in NOD mice. Exp Clin Endocrinol Diabetes 2008; 116 (8): 468-74.
70. Zhang J, Xie X, Li C, Fu P. Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models. J Ethnopharmacol 2009; 126 (2): 189-96.
71. Zhang WY, Li Wan Po A. The effectiveness of topically applied capsaicin. A meta-analysis. Eur J Clin Pharmacol 1994, 46 (6): 517-22.
72. Forst T, Pohlmann T, Kunt T, et al. The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathy. Acta Diabetol 2002;39 (1): 1-6.
73. Capsaicin Study Group. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992; 15 (2): 159-65.
74. Biesbroeck R, Bril V, Hollander P, et al. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther 1995, 12 (2): 111-20.
75. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group. Arch Intern Med 1991; 151 (11): 2225-9.
76. Nayak SB, Pinto Pereira L, Maharaj D. Wound healing activity of Carica papaya L. in experimentally induced diabetic rats. Indian J Exp Biol 2007; 45 (8): 739-43.
77. Ribaldo PDB, Souza DS, et al. Green tea (Camellia sinensis) attenuates nephropathy by downregulating nox4 NADPH oxidase in diabetic spontaneously hypertensive rats. J Nutr 2009; 139 (1): 96-100.
78. Yamabe N, Kang KS, Hur JM, Yokozawa T. Matcha, a powdered green tea, ameliorates the progression of renal and hepatic damage in type 2 diabetic OLETF rats. J Med Food 2009; 12 (4): 714-21.
79. Anandh Babu PV, Sabitha KE, Shyamaladevi CS. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 2006; 33 (12): 1184-9.
80. Babu PV, Sabitha KE, Shyamaladevi CS. Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chem Biol Interact 2006; 162 (2): 114-20.
81. Babu PV, Sabitha KE, Shyamaladevi CS. Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+ -ATPase and Na+/K+ -ATPase activity in the heart of streptozotocin-diabetic rats. Chem Biol Interact 2006; 162 (2): 157-64.
82. Mustata GT, Rosca M, Biemel KM, et al. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes 2005; 54 (2): 517-26.
83. Renno WM, Abdeen S, Alkhalaf M, Asfar S. Effect of green tea on kidney tubules of diabetic rats. Br J Nutr 2008; 100 (3) 652-9.
84. Yokozawa T, Nakagawa T, Oya T, Okubo T, Juneja LR. Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy. J Pharm Pharmacol 2005; 57 (6): 773-80.
85. Vinson JA, Zhang J. Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes. J Agric Food Chem 2005; 53 (9): 3710-3.
86. Incandela L, Belcaro G, Cesarone MR, et al. Treatment of diabetic microangiopathy and edema with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled randomized study. Angiology 2001; 52 (Suppl 2): S27-31.
87. Cesarone MR, Incandela L, De Sanctis MT, et al. Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella asiatica: a clinical prospective randomized trial with a microcirculatory model. Angiology 2001; (52 Suppl 2): S49-54.
88. Shukla A, Rasik AM, Jain GK, et al. In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol 1999; 65 (1): 1-11.
89. Kim SH, Hyun SH, Choung SY. Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver of diabetic mice. Biofactors 2006; 26 (3) 209-19.
90. Mishra A, Bhatti R, Singh A, Singh Ishar MP. Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med 2010; 76 (5): 412-7.
91. Grindley PB, Omoruyi FO, Asemota HN, Morrison EY. Effect of yam (Dioscorea cayenensis) and dasheen (Colocassia esculenta) extracts on the kidney of streptozotocin-induced diabetic rats. Int J Food Sci Nutr 2001; 52 (5): 429-33.
92. Suryanarayana P, Satyanarayana A, Balakrishna N, Kumar PU, Reddy GB. Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat. Med Sci Monit 2007; 13 (12): BR286-92.
93. Mrudula T, Suryanarayana P, Srinivas PN, Reddy GB. Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Bio- Chem Biophys Res Commun 2007; 361 (2): 528-32.
94. Chaturvedi A, Bhawani G, Agarwal PK, Goel S, Singh A, Goel RK. Antidiabetic and antiulcer effects of extract of Eugenia jambolana seed in mild diabetic rats: study on gastric mucosal offensive acid-pepsin secretion. Indian J Physiol Pharmacol 2009;53 (2): 137-46.
95. Chaturvedi A, Bhawani G, Agarwal PK, Goel S, Singh A, Goel RK. Ulcer healing properties of ethanolic extract of Eugenia jambolana seed in diabetic rats: study on gastric mucosal defensive factors. Indian J Physiol Pharmacol 2009; 53 (1): 16-24.
96. Ravi K, Ramachandran B, Subramanian S. Effect of Eugenia Jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats. Life Sci 2004; 75 (22): 2717-31.
97. Grover JK, Rathi SS, Vats V. Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucuna pruriens and Tinospora cordifolia) extracts. Indian J Exp Biol 2002; 40 (3): 273-6.
98. Grover JK, Vats V, Rathi SS, Dawar R. Traditional Indian antidiabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. J Ethnopharmacol 2001; 76 (3): 233-8.
99. Rathi SS, Grover JK, Vikrant V, Biswas NR. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res 2002; 16 (8): 774-7.
100. Stanely Mainzen Prince P, Kamalakkannan N, Menon VP. Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain. J Ethnopharmacol 2003; 84 (2-3) 205-9.
101. Prince PS, Menon VP, Pari L. Hypoglycaemic activity of Syzigium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. J Ethnopharmacol 1998, 61 (1): 1-7.
102. Logan JL, Benson B, Lee SM. Dietary fish oil enhances renal hypertrophy in experimental diabetes. Diabetes Res Clin Pract 1990, 10 (2): 137-45.
103. Kesavulu MM, Kameswararao B, Apparao C, Kumar EG, Harinarayan CV. Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes Metab 2002; 28 (1) 20-6.
104. Chiu WC, Hou YC, Yeh CL, Hu YM, Yeh SL. Effect of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in diabetic mice with sepsis. Br J Nutr 2007; 97 (4): 685-91.
105. Rizza S, Tesauro M, Cardillo C, et al. Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis 2009; 206 (2): 569-74.
106. He CY, Li WD, Guo SX, Lin SQ, Lin ZB. Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice. J Asian Nat Prod Res 2006; 8 (8): 705-11.
107. Lanthony P, Cosson JP. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study]. J Fr Ophtalmol 1988; 11 (10): 671-4.
108. Meng WL, Wang RJ, Yu J. Clinical observation on treatment of diabetic peripheral neuphropathy by ginkgo leaf extract combined with active vitamin B12. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24 (7): 645-6.
109. Zhu HW, Shi ZF, Chen YY. Effect of extract of ginkgo bilboa leaf on early diabetic nephropathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005; 25 (10): 889-91.
110. Li XS, Zheng WY, Lou SX, Lu XW, Ye SH. Effect of Ginkgo leaf extract on vascular endothelial function in patients with early stage diabetic nephropathy. Chin J Integr Med 2009; 15 (1): 26-9.
111. Lu Q, Yin XX, Wang JY, Gao YY, Pan YM. Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats. Acta Pharmacol Sin 2007; 28 (6): 818-28.
112. Azadbakht L, Atabak S, Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 2008; 31 (4): 648-54.
113. Ramkumar KM, Latha M, Venkateswaran S, Pari L, Ananthan R, Bai VN. Modulatory effect of Gymnema montanum leaf extract on brain antioxidant status and lipid peroxidation in diabetic rats J Med Food 2004; 7 (3): 366-71.
114. Ramkumar KM, Ponmanickam P, Velayuthaprabhu S, Archunan G, Rajaguru P. Protective effect of Gymnema montanum against renal damage in experimental diabetic rats. Food Chem Toxicol 2009; 47 (10): 2516-21.
115. Shukrimi A, Sulaiman AR, Halim AY, Azril A. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med J Malaysia 2008; 63 (1): 44-6.
116. Omotayo EO, Gurtu S, Sulaiman SA, Ab Wahab MS, Sirajudeen KN, Salleh MS. Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res 2010; 80 (1): 74-82.
117. McKay DL, Chen CY, Yeum KJ, Matthan NR, Lichtenstein AH, Blumberg JB. Chronic and acute effects of walnuts on antioxidant capacity and nutritional status in humans: a randomized, cross-over pilot study. Nutr J 2010; 9 (1): 21.
118. Velasquez MT, Bhathena SJ, Ranich T, et al. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Kidney Int 2003; 64 (6): 2100-7.
119. Pan A, Demark-Wahnefried W, Ye X, et al. Effects of a flaxseedderived lignan supplement on C-reactive protein, IL-6 and retinolbinding protein 4 in type 2 diabetic patients. Br J Nutr 2009; 101 (8): 1145-9.
120. Haliga R, Mocanu V, Paduraru I, Stoica B, Oboroceanu T, Luca V. Effects of dietary flaxseed supplementation on renal oxidative stress in experimental diabetes. Rev Med Chir Soc Med Nat Iasi 2009; 113 (4): 1200-4.
121. Li XM. Protective effect of Lycium barbarum polysaccharides on streptozotocin-induced oxidative stress in rats. Int J Biol Macromol 2007; 40 (5): 461-5.
122. Hong YH, Chao WW, Chen ML, Lin BF. Ethyl acetate extracts of alfalfa (Medicago sativa L.) sprouts inhibit lipopolysaccharideinduced inflammation in vitro and in vivo. J Biomed Sci 2009; 16,64.
123. Hong YH, Huang CJ, Wang SC, Lin, BF. The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice. Lupus 2009; 18 (3) 206-5.
124. Teoh SL, Latiff AA, Das S. The effect of topical extract of Momordica charantia (bitter gourd) on wound healing in nondiabetic rats and in rats with diabetes induced by streptozotocin. Clin Exp Dermatol 2009; 34 (7): 815-2.
125. Chandra A, Mahdi AA, Singh RK, Mahdi F, Chander R. Effect of Indian herbal hypoglycemic agents on antioxidant capacity and trace elements content in diabetic rats. J Med Food 2008; 11 (3): 506-12.
126. Kumar GS, Shetty AK, Salimath PV. Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats. J Ethnopharmacol 2008; 115 (2): 276-83.
127. Sathishsekar D, Subramanian S. Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats. Asia Pac J Clin Nutr 2005; 14 (2): 153-8.
128. Teoh SL, Abd Latiff A, Das S. Histological changes in the kidneys of experimental diabetic rats fed with Momordica charantia (bitter gourd) extract. Rom. J Morphol Embryol 2010; 51 (1): 91-5.
129. Chaturvedi P, George S. Momordica charantia maintains normal glucose levels and lipid profiles and prevents oxidative stress in diabetic rats subjected to chronic sucrose load. J Med Food 2010;13 (3): 520-7.
130. Ford I, Cotter MA, Cameron NE, Greaves M. The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metab Clin Exp 2001; 50 (8): 868-75.
131. Hamden K, Allouche N, Damak M, Elfeki A. Hypoglycemic and antioxidant effects of phenolic extracts and purified hydroxytyrosol from olive mill waste in vitro and in rats. Chem Biol Interact 2009;180 (3): 421-32.
132. Medeiros FJ, Aguila MB, Mandarim-de-Lacerda CA. Renal cortex remodeling in streptozotocin-induced diabetic spontaneously hypertensive rats treated with olive oil, palm oil and fish oil from Menhaden. Prostaglandins Leukot Essent Fatty Acids 2006; 75 (6): 357-65.
133. Zhao GH, Shen YS, Ma JB, Li F, Shi XQ. Protection of polysaccharides-2b from mudan cortex of Paeonia suffruticosa andr on diabetic cataract in rats. Zhongguo Zhong Yao Za Zhi 2007; 32 (19) 2036-9.
134. Kim HY, Kang KS, Yamabe N, Nagai R, Yokozawa T. Protective effect of heat-processed American ginseng against diabetic renal damage in rats. J Agric Food Chem 2007; 55 (21): 8491-7.
135. Kang KS, Kim HY, Yamabe N, Nagai R, Yokozawa, T. Protective effect of sun ginseng against diabetic renal damage. Biol Pharm Bull 2006; 29 (8): 1678-84.
136. Lang J, Cao H, Wei A. [Comparative study on effect of Panax notoginseng and ticlid in treating early diabetic nephropathy]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1998, 18 (12): 727-9.
137. Zhao L, Lan LG, Min XL, et al. [Integrated treatment of traditional Chinese medicine and western medicine for early- and intermediate-stage diabetic nephropathy]. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27 (7): 1052-5.
138. Ryu JK, Lee T, Kim DJ, Park et al. Free radical-scavenging activity of Korean red ginseng for erectile dysfunction in noninsulin- dependent diabetes mellitus rats. Urology 2005; 65 (3): 611-5.
139. Yang CY, Xie ZG, Cheng WB, Jiang X, Chen ZH. Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice. Zhong Yao Cai 2009; 32 (10): 1571-6.
140. Cesarone MR, Belcaro G, Rohdewald P, et al. Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. Angiology 2006; 57 (4): 431-6.
141. Belcaro G, Cesarone MR, Errichi BM, et al. Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. Clin Appl Thromb Hemost 2006; 12 (3): 318-23.
142. Spadea L, Balestrazzi E. Treatment of vascular retinopathies with Pycnogenol. Phytother Res 2001; 15 (3): 219-23.
143. Dong W, Shi HB, Ma H, Miao YB, Liu TJ, Wang W. Homoisoflavanones from Polygonatum odoratum rhizomes inhibit advanced glycation end product formation. Arch Pharm Res 2010;33 (5): 669-74.
144. McLennan SV, Bonner J, Milne S, et al. The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes. Wound Repair Regen 2008; 16 (5): 706-13.
145. Lotfy M, Badra G, Burham W, Alenzi FQ. Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus. Br J Biomed Sci 2006; 63 (4): 171-3.
146. Abo-Salem OM, El-Edel RH, Harisa GE, El-Halawany N, Ghonaim MM. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters. Pak J Pharm Sci 2009; 22 (2): 205-10.
147. Bebrevska L, Foubert K, Hermans N, et al. In vivo antioxidative activity of a quantified Pueraria lobata root extract. J Ethnopharmacol 2010; 127 (1): 112-7.
148. Rosenblat M, Hayek T, Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 2006; 187 (2): 363-71.
149. Fenercioglu AK, Saler T, Genc E, Sabuncu H, Altuntas Y. The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications. J Endocrinol Invest 2010; 33 (2): 118-24.
150. Huang TH, Yang Q, Harada M, Li GQ, Yamahara J, Roufogalis BD, Li Y. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. J Cardiovasc Pharmacol 2005; 46 (6): 856-62.
151. de Nigris F, Balestrieri ML, Williams-Ignarro S, et al. The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide 2007; 17 (1): 50-4.
152. Rock W, Rosenblat M, Miller-Lotan R, Levy AP, Elias M, Aviram M. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. J Agric Food Chem 2008; 56 (18): 8704-13.
153. Bagri P, Ali M, Aeri V, Bhowmik M, Sultana S. Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food Chem Toxicol 2009; 47 (1): 50-4.
154. Fuhrman B, Volkova N, Aviram M. Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to highdensity lipoprotein: studies in vitro and in diabetic patients. Nutrition 2010; 26 (4): 359-66.
155. Mohan M, Waghulde H, Kasture S. Effect of pomegranate juice on Angiotensin II-induced hypertension in diabetic wistar rats. Phytother Res 2009; 24 (S2): S196-203.
156. Lau TW, Lam FF, Lau KM, et al. Pharmacological investigation on the wound healing effects of Radix Rehmanniae in an animal model of diabetic foot ulcer. J Ethnopharmacol 2009; 123 (1): 155-62.
157. Waisundara VY, Huang M, Hsu A, Huang D, Tan BK. Characterization of the anti-diabetic and antioxidant effects of rehmannia glutinosa in streptozotocin-induced diabetic Wistar rats. Am J Chin Med 2008; 36 (6): 1083-4.
158. Takako Y, Li-Qun H, Yasuko M, Rika N, Masao H, Hikokichi O. Effects of rhubarb extract in rats with diabetic nephropathy. Phytother Res 2097, 11 (1): 73-5.
159. Vuksan V, Whitham D, Sievenpiper JL, et al. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 2007; 30 (11): 2804-10.
160. Yue KK, Lee KW, Chan KK, Leung KS, Leung AW, Cheng CH. Danshen prevents the occurrence of oxidative stress in the eye and aorta of diabetic rats without affecting the hyperglycemic state. J Ethnopharmacol 2006; 106 (1): 136-41.
161. Liu G, Guan GJ, Qi TG, et al. Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism. Zhong Xi Yi Jie He Xue Bao 2005; 3 (6): 459-62.
162. Wu HN, Sun H. Study on clinical therapeutic effect of composite Salvia injection matched with Western medicine in treating diabetic foot. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003; 23 (10): 727-9.
163. Zhang M, Li X, Qin G, Liu Y, Zhao X. Effects of Danshen injection on the reserve of tissue plasminogen activator and nitric oxide in endothelium and vasodilatation in diabetic patients. Zhong Yao Cai 2005; 28 (6): 529-32.
164. Vessal G, Akmali M, Najafi P, Moein MR, Sagheb MM. Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Ren Fail 2010;32 (6): 733-9.
165. Purandare H, Supe A. Immunomodulatory role of Tinospora cordifolia as an adjuvant in surgical treatment of diabetic foot ulcers: a prospective randomized controlled study. Indian J Med Sci 2007; 61 (6): 347-55.
166. Preet A, Siddiqui MR, Taha A, et al. Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues. Mol Cell Biochem 2006; 289 (1-2): 137-47.
167. Matsunaga N, Imai S, Inokuchi Y, et al. Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo. Mol Nutr Food Res 2009; 53 (7): 869-77.
168. Cui XP, Li BY, Gao HQ, Wei N, Wang WL, Lu M. Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats. J Nutr Sci Vitaminol (Tokyo) 2008; 54 (4): 321-8.
169. Kar P, Laight D, Rooprai HK, Shaw KM, Cummings M. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabet Med 2009; 26 (5): 526-31.
170. Kiyici A, Okudan N, Gokbel H, Belviranli M. The effect of grape seed extracts on serum paraoxonase activities in streptozotocininduced diabetic rats. J Med Food 2010; 13 (3): 725-8.
171. Li BY, Cheng M, Gao HQ, et al. Back-regulation of six oxidative stress proteins with grape seed proanthocyanidin extracts in rat diabetic nephropathy. J Cell Biochem 2008; 104 (2): 668-79.
172. Li M, Ma YB, Gao HQ, et al. A novel approach of proteomics to study the mechanism of action of grape seed proanthocyanidin extracts on diabetic retinopathy in rats. Chin Med J (Engl) 2008;121 (24): 2544-52.
173. Li X, Xiao Y, Gao H, et al. Grape seed proanthocyanidins ameliorate diabetic nephropathy via modulation of levels of AGE, RAGE and CTGF. Nephron Exp Nephrol 2009; 111 (2): e31-41.
174. Liu YN, Shen XN, Yao GY. Effects of grape seed proanthocyanidins extracts on experimental diabetic nephropathy in rats. Wei Sheng Yan Jiu 2006; 35 (6): 703-5.
175. Udayakumar R, Kasthurirengan S, Vasudevan A, et al. Antioxidant effect of dietary supplement Withania somnifera L. reduce blood glucose levels in alloxan-induced diabetic rats. Plant Foods Hum Nutr 2010; 65 (2): 91-8.
176. Parihar MS, Chaudhary M, Shetty R, Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 2004; 11 (4): 397-402.
177. Ojewole JA. Analgesic antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother Res 2006 20 (9): 764-72.
178. Li GS, Jiang WL, Yue XD, et al. Effect of Astilbin on Experimental Diabetic Nephropathy in vivo and in vitro. Planta Med 2009; 75 (14): 1470-5.
179. Yu J, Zhang Y, Sun S, et al. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can J Physiol Pharmacol 2006; 84 (6): 579-87.
180. Yin X, Zhang Y, Wu H, et al. Protective effects of Astragalus saponin I on early stage of diabetic nephropathy in rats. J Pharmacol Sci 2004; 95 (2): 256-66.
181. Yang LP, Sun HL, Wu LM, et al. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Invest Ophthalmol Vis Sci 2009; 50 (5): 2319-27.
182. Liu WH, Hei ZQ, Nie H, et al. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J (Engl) 2008; 121 (8): 706-12.
183. Qi XM, Wu GZ, Wu YG, Lin H, Shen JJ, Lin SY. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats. Nephron Exp Nephrol 2006; 104 (4): e147-57.
184. Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-[kappa]B. Nutrition 2009; 25 (9): 964-72.
185. Sharma S, Chopra K, Kulkarni SK. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 2007; 21 (3): 278-83.
186. Sharma S, Kulkarni SK, Chopra K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2006; 33 (10): 940-5.
187. Sidhu GS, Mani H, Gaddipati JP, et al. Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 1999; 7 (5): 362-74.
188. Kowluru RA, Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 2007; 4, 8.
189. Bertuglia S, Malandrino S, Colantuoni A. Effects of the natural flavonoid delphinidin on diabetic microangiopathy. Arzneimittelforschung 1995, 45 (4): 481-5.
190. Arnal E, Miranda M, Johnsen-Soriano S, et al. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr Eye Res 2009; 34 (11): 928-38.
191. Yamabe N, Yokozawa T, Oya T, Kim M. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther 2006; 319 (1): 228-36.
192. Kim H, Kawazoe T, Han DW, et al. Enhanced wound healing by an epigallocatechin gallate-incorporated collagen sponge in diabetic mice. Wound Repair Regen 2008; 16 (5): 714-20.
193. Roghani M, Baluchnejadmojarad T. Chronic epigallocatechingallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul Pharmacol 2009; 51 (2-3): 84-9.
194. Nangle MR, Gibson TM, Cotter MA, Cameron NE. Effects of eugenol on nerve and vascular dysfunction in streptozotocindiabetic rats. Planta Med 2006; 72 (6): 494-500.
195. Nakajima M, Cooney MJ, Tu AH, et al. Normalization of retinal vascular permeability in experimental diabetes with genistein. Invest Ophthalmol Vis Sci 2001; 42 (9): 2110-4.
196. Aida K, Tawata M, Shindo H, et al. Isoliquiritigenin: A new aldose reductase inhibitor from glycyrrhizae radix. Planta Med 1990, 56 (03): 254-8.
197. Jamal GA, Carmichael H. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebocontrolled trial. Diabet Med 1990, 7 (4): 319-23.
198. Sena CM, Nunes E, Louro T, et al. Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br J Pharmacol 2008; 153 (5): 894-906.
199. Lee GT, Ha H, Jung M, et al. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J Am Soc Nephrol 2003; 14 (3): 709-20.
200. Kang ES, Lee GT, Kim BS, et al. Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats. Eur J Pharmacol 2008; 579 (1-3): 418-25.
201. Zhao R, Li QW, Li J, Zhang T. Protective effect of Lycium barbarum polysaccharide 4 on kidneys in streptozotocin-induced diabetic rats. Can. J Physiol Pharmacol 2009; 87 (9): 711-9.
202. Sohn EJ, Kim CS, Kim YS, et al. Effects of magnolol (5,5'-diallyl- 2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Life Sci 2007; 80 (5): 468-75.
203. Kang KS, Yamabe N, Kim HY, Yokozawa T. Role of maltol in advanced glycation end products and free radicals: in-vitro and invivo studies. J Pharm Pharmacol 2008; 60 (4): 445-52.
204. Li X, Cui X, Sun X, Zhu Q, Li W. Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Phytother Res 2010; 24 (6): 893-9.
205. Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 2005; 97 (3): 497-501.
206. Mapanga RF, Tufts MA, Shode FO, Musabayane CT. Renal effects of plant-derived oleanolic acid in streptozotocin-induced diabetic rats. Ren Fail 2009; 31 (6): 481-91.
207. Kim YS, Kim NH, Lee SW, Lee YM, Jang DS, Kim JS. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-[beta]1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats. Eur J Pharmacol 2007; 569 (3): 171-9.
208. Teng Y, Cui H, Yang M, Song H, Zhang Q, Su Y, Zheng J. Protective effect of puerarin on diabetic retinopathy in rats. Mol Biol Rep 2009; 36 (5): 1129-33.
209. Zhu LH, Wang L, Wang D, et al. Puerarin attenuates high-glucoseand diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2/Rac1-dependent signaling. Free Radic Biol Med 2010; 48 (4): 471-82.
210. Anjaneyulu M, Chopra K. Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog. NeuropsychoPharmacol Biol Psychiatry 2003; 27 (6): 1001-5.
211. Anjaneyulu M, Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004; 31 (4): 244-8.
212. Anjaneyulu M, Chopra K. Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J Exp Biol 2004; 42 (8): 766-9.
213. Sharma S, Kulkarni SK, Chopra K. Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J Exp Biol 2006; 44 (7): 566-9.
214. Gao Q, Qin WS, Jia ZH, et al. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med 2010; 76 (01): 27-33.
215. Kamalakkannan N, Stanely Mainzen Prince P. The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney. J Pharm Pharmacol 2006; 58 (8): 1091-8.
216. Chen YL, Huang HC, Weng YI, Yu YJ, Lee YT. Morphological evidence for the antiatherogenic effect of scoparone in hyperlipidaemic diabetic rabbits. Cardiovasc Res 1994, 28 (11): 1679-85.
217. Luo P, Tan ZH, Zhang ZF, Zhang H, Liu XF, Mo ZJ. Scutellarin isolated from erigeron multiradiatus inhibits high glucose-mediated vascular inflammation. Yakugaku Zasshi 2008; 128 (9): 1293-9.
218. Jeong SI, Kim KJ, Choi MK, et al. alpha-Spinasterol isolated from the root of Phytolacca americana and its pharmacological property on diabetic nephropathy. Planta Med 2004; 70 (8): 736-9.
219. Kim SK, Jung KH, Lee BC. Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy. Biol Pharm Bull 2009; 32 (2): 220-4.
220. Kobayashi S, Kimura I, Fukuta M, et al. Inhibitory effects of tetrandrine and related synthetic compounds on angiogenesis in streptozotocin-diabetic rodents. Biol Pharm Bull 1999; 22 (4): 360-5.
221. Chung HK, Choi SM, Ahn BO, Kwak HH, Kim JH, Kim WB. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy. Arzneimittelforschung 2005; 55 (10): 573-80.
222. Wigg SJ, Tare M, Forbes J, et al. Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia 2004; 47 (6): 1038-46.
223. Oh YT, Lee JY, Lee J, et al. Oleic acid reduces lipopolysaccharideinduced expression of iNOS and COX-2 in BV2 murine microglial cells: Possible involvement of reactive oxygen species, p38 MAPK, and IKK/NF-[kappa]B signaling pathways. Neurosci Lett 2009;464 (2): 93-7.
224. Carluccio MA, Massaro M, Bonfrate C, et al. Raffaele de caterina, oleic acid inhibits endothelial activation: a direct vascular antiatherogenic mechanism of a nutritional component in the mediterranean diet. Arterioscler Thromb Vasc Biol 1999; 20 (2): 220-8.
225. Dirsch VM, Kiemer AK, Wagner H, Vollmar AM. Effect of allicin and ajoene, two compounds of garlic, on inducible nitric oxide synthase. Atherosclerosis 1998; 139 (2): 333-9.
226. Hasan N, Yusuf N, Toossi Z, Islam N. Suppression of Mycobacterium tuberculosis induced reactive oxygen species (ROS) and TNF-[alpha] mRNA expression in human monocytes by allicin. FEBS Lett 2006; 580 (10): 2517-22.
227. Liu C, Cao F, Tang QZ, et al. Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen speciesdependent signaling pathways. J Nutr BioChem 2010; 21(12): 1238-50.
228. Son EW, Mo SJ, Rhee DK, Pyo S. Inhibition of ICAM-1 expression by garlic component, allicin, in gamma-irradiated human vascular endothelial cells via downregulation of the JNK signaling pathway. Int Immunopharmacol 2006; 6 (12): 1788-95.
229. Liu KL, Chen HW, Wang RY, Lei YP, Sheen LY, Lii CK. DATS reduces LPS-induced iNOS expression, NO production, oxidative stress, and NF-κB activation in RAW 264.7 macrophages. J Agric Food Chem 2006; 54 (9): 3472-8.
230. Lei YP, Chen HW, Sheen LY, Lii CK. Diallyl disulfide and diallyl trisulfide suppress oxidized LDL-induced vascular cell adhesion molecule and E-selectin expression through protein kinase A- and B-dependent signaling pathways. J Nutr 2008; 138 (6): 996-1003.
231. Chiang YH, Jen LN, Su HY, Lii CK, Sheen LY, Liu CT. Effects of garlic oil and two of its major organosulfur compounds, diallyl disulfide and diallyl trisulfide, on intestinal damage in rats injected with endotoxin. Toxicol Appl Pharmacol 2006; 213 (1): 46-54.
232. Zeng T, Zhang CL, Zhu ZP, Yu LH, Zhao XL, Xie KQ. Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanolexposed mice. Toxicology 2008; 252 (1-3): 86-91.
233. Chen FL, Yang ZH, Liu Y, et al. Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway. Endocrine 2008; 33 (3): 331-7.
234. Hsiang CY, Wu SL, Cheng SE, Ho TY. Acetaldehyde-induced interleukin-1beta and tumor necrosis factor-alpha production is inhibited by berberine through nuclear factor-kappaB signaling pathway in HepG2 cells. J Biomed Sci 2005; 12 (5): 791-801.
235. Ko YJ, Lee JS, Park BC, Shin HM, Kim JA. Inhibitory effects of Zoagumhwan water extract and berberine on angiotensin IIinduced monocyte chemoattractant protein (MCP)-1 expression and monocyte adhesion to endothelial cells. Vasc Pharmacol 2007; 47 (2-3): 189-96.
236. Wang Y, Huang Y, Lam KSL, et al. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res 2009; 82 (3): 484-92.
237. Zhao X, Zhang JJ, Wang X, Bu XY, Lou YQ, Zhang GL. Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats. Biomed Pharmacother 2008; 62 (9: 567-72.
238. Zhou XQ, Zeng XN, Kong H, Sun XL. Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci Lett 2008;447 (1): 31-6.
239. Kumar S, Singhal V, Roshan R, Sharma A, Rembhotkar GW, Ghosh B. Piperine inhibits TNF-[alpha] induced adhesion of neutrophils to endothelial monolayer through suppression of NF- [kappa]B and I[kappa]B kinase activation. Eur J Pharmacol 2007;575 (1-3): 177-86.
240. Pradeep CR, Kuttan G. Effect of Piperine on the Inhibition of Nitric Oxide (NO) and TNFα Production. ImmunoPharmacol Immunotoxicol 2003; 25 (3): 337-46.
241. Pradeep CR, Kuttan G. Piperine is a potent inhibitor of nuclear factor-[kappa]B (NF-[kappa]B), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. Int Immunopharmacol 2004; 4 (14): 1795-803.
242. Selvendiran K, Singh JPV, Krishnan KB, Sakthisekaran D. Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia 2003; 74 (1-2): 109-15.
243. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T. Inhibitory effect of serotonin derivatives on high glucose-induced adhesion and migration of monocytes on human aortic endothelial cells. Br. J Nutr 2009; 102 (02): 264-72.
244. Liu YC, Hsieh CW, Wu CC, Wung BS. Chalcone inhibits the activation of NF-[kappa]B and STAT3 in endothelial cells via endogenous electrophile. Life Sci 2007; 80 (15): 1420-30.
245. Anto RJ, Sukumaran K, Kuttan G, Rao MNA, Subbaraju V, Kuttan R. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett 1995; 97: 33-7.
246. Han JM, Lee WS, Kim JR, et al. Effect of 5- O-methylhirsutanonol on nuclear factor-κB-dependent production of NO and expression of iNOS in lipopolysaccharide-induced RAW264.7 cells. J Agric Food Chem 2007; 56 (1): 92-8.
247. Han JM, Lee WS, Kim JR, et al. Effects of diarylheptanoids on the tumor necrosis factor-α-induced expression of adhesion molecules in human umbilical vein endothelial cells. J Agric Food Chem 2007; 55 (23): 9457-64.
248. Yang F, de Villiers WJS, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factorproduction and lethality in a murine model. J Nutr 2098; 128 (12): 2334-40.
249. Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1[beta]-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 2002; 33 (8): 1097-105.
250. Morikawa K, Ikeda C, Nonaka M, et al. Epigallocatechin gallateinduced apoptosis does not affect adipocyte conversion of preadipocytes. Cell Biol Int 2007; 31 (11): 1379-87.
251. Hong MH, Kim MH, Chang HJ, et al. (-)-Epigallocatechin-3- gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-[kappa]B signaling. Life Sci 2007; 80 (21) 1957-1965.
252. Chae YJ, Kim CH, Ha TS, Hescheler J, Ahn HY, Sachinidis A. Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways. Cell Physiol Biochem 2007;20 (6): 859-66.
253. Ahn HY, Xu Y, Davidge ST. Epigallocatechin-3-O-gallate inhibits TNF[alpha]-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci 2008; 82 (17-18): 964-8.
254. Ludwig A, Lorenz M, Grimbo N, et al. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. BioChem Biophys. Res Commun 2004; 316 (3): 659-65.
255. Raza H, John A. In vitro protection of reactive oxygen speciesinduced degradation of lipids, proteins and 2-deoxyribose by tea catechins. Food Chem Toxicol 2007; 45 (10): 1814-20.
256. Meng Q, Velalar CN, Ruan R. Effects of epigallocatechin-3-gallate on mitochondrial integrity and antioxidative enzyme activity in the aging process of human fibroblast. Free Radic Biol Med 2008; 44 (6): 1032-41.
257. Jimenez-Lopez JM, Cederbaum AI. Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1- dependent toxicity. Free Radic Biol Med 2004; 36 (3): 359-70.
258. Gerritsen ME, Carley WW, Ranges GE, et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 1995, 147 (2): 278-92.
259. Smolinski AT, Pestka JJ. Modulation of lipopolysaccharideinduced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb1 (ginseng) and parthenolide (feverfew). Food Chem Toxicol 2003;41 (10): 1381-90.
260. Jeong GS, Lee SH, Jeong SN, Kim YC, Kim EC. Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharidestimulated human periodontal ligament cells via heme oxygenase-1. Int Immunopharmacol 2009; 9 (12): 1374-80.
261. Mueller M, Hobiger S, Jungbauer A. Anti-inflammatory activity of extracts from fruits, herbs and spices. Food Chem 2010; 122 (4): 987-96.
262. Liang YC, Tsai SH, Tsai DC, Lin-Shiau SY, Lin JK. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-[gamma] by flavonoids in mouse macrophages. FEBS Lett 2001; 496 (1): 12-8.
263. Chen CC, Chow MP, Huang WC, Lin YC, Chang YJ. Flavonoids inhibit tumor necrosis factor-α-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-κB: structure-activity relationships. Mol Pharmacol 2004; 66 (3): 683-93.
264. Choi JS, Choi YJ, Park SH, Kang JS, Kang YH. Flavones mitigate tumor necrosis factor-{alpha}-induced adhesion molecule upregulation in cultured human endothelial cells: role of nuclear factor-{kappa}B. J Nutr 2004; 134 (5): 1013-9.
265. Lotito SB, Frei B. Dietary flavonoids attenuate tumor necrosis factor α-induced adhesion molecule expression in human aortic endothelial cells. J Biol Chem 2006; 281 (48): 37102-10.
266. Jeong YJ, Choi YJ, Choi JS, et al. Attenuation of monocyte adhesion and oxidised LDL uptake in luteolin-treated human endothelial cells exposed to oxidised LDL. Br J Nutr 2007; 97 (03): 447-57.
267. Lii CK, Lei YP, Yao HT, et al. Chrysanthemum morifolium Ramat. reduces the oxidized LDL-induced expression of intercellular adhesion molecule-1 and E-selectin in human umbilical vein endothelial cells. J Ethnopharmacol 2010; 128 (1): 213-20.
268. Blonska M, Bronikowska J, Pietsz G, Czuba ZP, Scheller S, Krol W. Effects of ethanol extract of propolis (EEP) and its flavones on inducible gene expression in J774A.1 macrophages. J Ethnopharmacol 2004; 91 (1): 25-30.
269. Li X, Huang Q, Ong CN, Yang XF, Shen HM. Chrysin sensitizes tumor necrosis factor-[alpha]-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB. Cancer Lett 2010;293 (1): 109-16.
270. Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 Cells. J Nutr 2006; 136 (6): 1517-21.
271. Crespo I, Garcia-Mediavilla MV, Gutierrez B, et al. A comparison of the effects of kaempferol and quercetin on cytokine-induced proinflammatory status of cultured human endothelial cells. Br J Nutr 2008; 100 (5): 968-76.
272. Rostoka E, Baumane L, Isajevs S, et al. Effects of kaempferol and myricetin on inducible nitric oxide synthase expression and nitric oxide production in rats. Basic Clin Pharmacol Toxicol 2010; 106 (6): 461-6.
273. Kim JD, Liu L, Guo W, Meydani M. Chemical structure of flavonols in relation to modulation of angiogenesis and immuneendothelial cell adhesion. J Nutr Biochem 2006; 17 (3): 165-76.
274. Singh R, Singh B, Singh S, Kumar N, Kumar S, Arora S. Anti-free radical activities of kaempferol isolated from Acacia nilotica (L.) Willd. Ex. Del. Toxicol In Vitro 2008; 22 (8): 1965-70.
275. Wattel A, Kamel S, Mentaverri R, et al. Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. BioChem Pharmacol 2003; 65 (1): 35-42.
276. Kim JA, Kim DK, Kang OH, et al. Inhibitory effect of luteolin on TNF-[alpha]-induced IL-8 production in human colon epithelial cells. Int Immunopharmacol 2005; 5 (1) 209-17.
277. Ding L, Jin D, Chen X. Luteolin enhances insulin sensitivity via activation of PPAR[gamma] transcriptional activity in adipocytes. J Nutr Biochem 2010; 21(10): 941-7.
278. Park HH, Lee S, Son HY, et al. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharm Res 2008; 31 (10): 1303-11.
279. Wang ZH, Ah Kang K, Zhang R, et al. Myricetin suppresses oxidative stress-induced cell damage via both direct and indirect antioxidant action. Environ Toxicol Pharmacol 2010; 29 (1): 12-8.
280. Reiterer G, Toborek M, Hennig B. Quercetin protects against linoleic acid-induced porcine endothelial cell dysfunction. J Nutr 2004; 134 (4): 771-5.
281. Shen SC, Lee WR, Lin HY, et al. In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharideinduced nitric oxide and prostaglandin E2 production. Eur J Pharmacol 2002; 446 (1-3): 187-94.
282. Koga T, Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 2001; 73 (5): 941-8.
283. Kobuchi H, Roy S, Sen CK, Nguyen HG, Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol Cell Physiol 1999; 277 (3): C403-11.
284. Sánchez-Gallego JI, López-Revuelta A, Sardina JL, Hernández-Hernández Á, Sánchez-Yagüe J, Llanillo M. Membrane cholesterol contents modify the protective effects of quercetin and rutin on integrity and cellular viability in oxidized erythrocytes. Free Radic Biol Med 2010; 48 (10): 1444-54.
285. Hong H, Liu GQ. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci 2004; 74 (24): 2959-73.
286. Piao HZ, Jin SA, Chun HS, Lee JC, Kim WK. Neuroprotective effect of wogonin: potential roles of inflammatory cytokines. Arch Pharm Res 2004; 27 (9): 930-6.
287. Nakamura N, Hayasaka S, Zhang XY, et al. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-[kappa]b binding activities induced by interleukin-1[beta] in human retinal pigment epithelial cell line. Exp Eye Res 2003; 77 (2) 195-202.
288. Chi YS, Lim H, Park H, Kim HP. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. BioChem Pharmacol 2003; 66 (7): 1271-8.
289. Huang GC, Chow JM, Shen SC, et al. Wogonin but not Norwogonin inhibits lipopolysaccharide and lipoteichoic acid-induced iNOS gene expression and NO production in macrophages. Int Immunopharmacol 2007; 7 (8): 1054-63.
290. Sook Chi Y, Sun Cheon B, Pyo Kim H. Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in lipopolysaccharide-treated RAW 264.7 cells. BioChem Pharmacol 2001; 61 (10): 1195-203.
291. Kim H, Kim YS, Kim SY, Suk K. The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci Lett 2001; 309 (1): 67-71.
292. Lee SO, Jeong YJ, Yu MH, et al. Wogonin suppresses TNF- [alpha]-induced MMP-9 expression by blocking the NF-[kappa]B activation via MAPK signaling pathways in human aortic smooth muscle cells. BioChem Biophys Res Commun 2006; 351 (1): 118-25.
293. Piao HZ, Choi IY, Park JS, et al. Wogonin inhibits microglial cell migration via suppression of nuclear factor-kappa B activity. Int Immunopharmacol 2008; 8 (12): 1658-62.
294. Chang YL, Shen JJ, Wung BS, Cheng JJ, Wang DL. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol Pharmacol 2001;60 (3): 507-13.
295. Cho J, Lee HK. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells. Eur J Pharmacol 2004; 485 (1-3): 105-10.
296. Lee WR, Shen SC, Lin HY, et al. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca2+-dependent endonuclease. BioChem Pharmacol 2002; 63 (2): 225-36.
297. Tse AKW, Wan CK, Zhu GY, et al. Magnolol suppresses NF- [kappa]B activation and NF-[kappa]B regulated gene expression through inhibition of IkappaB kinase activation. Mol Immunol 2007; 44 (10): 2647-58.
298. Choi SS, Cha BY, Lee YS, et al. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Life Sci 2009;84 (25-26): 908-14.
299. Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL. Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol 2002; 135 (1): 37-47.
300. Chen YL, Lin KF, Shiao MS, Chen YT, Hong CY, Lin SJ. Magnolol a potent antioxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits. Basic Res Cardiol 2001; 96 (4): 353-63.
301. Shen YC, Sung YJ, Chen CF. Magnolol inhibits Mac-1 (CD11b/CD18)-dependent neutrophil adhesion: Relationship with its antioxidant effect. Eur J Pharmacol 1998, 343 (1): 79-86.
302. Kozela E, Pietr M, Juknat A, Rimmerman N, Levy R, Vogel Z. Cannabinoids {increment}9-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-κB and interferon-β/STAT proinflammatory pathways in BV-2 microglial cells. J Biol Chem 2010; 285 (3): 1616-26.
303. Napimoga MH, Benatti BB, Lima FO, et al. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and proinflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol 2009; 9 (2): 216-22.
304. Pan H, Mukhopadhyay P, Rajesh M, et al. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J Pharmacol Exp Ther 2009; 328 (3): 708-14.
305. Yu YM, Wang ZH, Liu CH, Chen CS. Ellagic acid inhibits IL-1β- induced cell adhesion molecule expression in human umbilical vein endothelial cells. Br J Nutr 2007; 97 (04): 692-8.
306. Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 2008; 99 (04): 715-22.
307. Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem 2002; 50 (7): 2200-6.
308. Murase T, Kume N, Hase T, et al. Gallates inhibit cytokineinduced nuclear translocation of NF-{kappa}B and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler. Thromb Vasc Biol 1999; 19 (6): 1412-20.
309. Hsieh TJ, Liu TZ, Chia YC, et al. Protective effect of methyl gallate from Toona sinensis (Meliaceae) against hydrogen peroxide-induced oxidative stress and DNA damage in MDCK cells. Food Chem Toxicol 2004; 42 (5): 843-50.
310. Han YH, Park WH. Propyl gallate inhibits the growth of HeLa cells via regulating intracellular GSH level. Food Chem Toxicol 2009;47 (10): 2531-8.
311. Lu Z, Nie G, Belton PS, Tang H, Zhao B. Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. NeuroChem Int 2006; 48 (4): 263-74.
312. Beck POd, Cartier G, David B, Dijoux-Franca MG, Mariotte AM. Antioxidant flavonoids and phenolic acids from leaves of Leea guineense G. Don (Leeaceae). Phytother Res 2003; 17 (4): 345-7.
313. Hao J, Shen W, Yu G, Jia H, et al. Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes. J Nutr Biochem 2010; 21(7): 634-44.
314. Carluccio MA, Siculella L, Ancora MA, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 2003; 23 (4): 622-9.
315. Zhang X, Cao J, Zhong L. Hydroxytyrosol inhibits proinflammatory cytokines, iNOS, and COX-2 expression in human monocytic cells. Naunyn Schmiedebergs Arch Pharmacol 2009;379 (6): 581-586.
316. Visioli F, Bellomo G, Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 1998,247 (1): 60-4.
317. Deiana M, Aruoma OI, Bianchi MdLP, et al. Inhibition of peroxynitrite dependent DNA base modification and tyrosine nitration by the extra virgin olive oil-derived antioxidant hydroxytyrosol. Free Radic Biol Med 1999; 26 (5-6): 762-9.
318. Zhang X, Cao J, Jiang L, Geng C, Zhong L. Protective effect of hydroxytyrosol against acrylamide-induced cytotoxicity and DNA damage in HepG2 cells. Mutat Res 2009; 664 (1-2): 64-8.
319. Zhou Z, Liu Y, Miao AD, Wang SQ. Protocatechuic aldehyde suppresses TNF-[alpha]-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur J Pharmacol 2005;513 (1-2): 1-8.
320. Kim KJ, Kim MA, Jung JH. Antitumor and antioxidant activity of protocatechualdehyde produced from Streptomyces lincolnensis M-20. Arch Pharm Res 2008; 31 (12): 1572-7.
321. Choi JH, Jeong TS, Kim DY, et al. Hematein inhibits atherosclerosis by inhibition of reactive oxygen generation and NF- [kappa]B-dependent inflammatory mediators in hyperli-pidemic mice. J Cardiovasc Pharmacol 2003; 42 (2): 287-95.
322. Taeg Oh G, Hoon Choi J, Joo Hong J, et al. Dietary hematein ameliorates fatty streak lesions in the rabbit by the possible mechanism of reducing VCAM-1 and MCP-1 expression. Atherosclerosis 2001; 159 (1): 17-26.
323. Hu S, Shen G, Zhao W, Wang F, Jiang X, Huang D. Paeonol, the main active principles of Paeonia moutan, ameliorates alcoholic steatohepatitis in mice. J Ethnopharmacol 2010; 128 (1): 100-6.
324. Ishiguro K, Ando T, Maeda O, et al. Paeonol attenuates TNBSinduced colitis by inhibiting NF-[kappa]B and STAT1 transactivation. Toxicol Appl Pharmacol 2006; 217 (1): 35-42.
325. Kim SH, Kim SA, Park MK, et al. Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-[alpha]. Int Immunopharmacol 2004; 4 (2): 279-87.
326. Nizamutdinova IT, Oh HM, Min YN, et al. Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-[alpha]-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-[kappa]B signaling pathways. Int Immunopharmacol 2007; 7 (3): 343-50.
327. Pan LL, Dai M. Paeonol from Paeonia suffruticosa prevents TNF- [alpha]-induced monocytic cell adhesion to rat aortic endothelial cells by suppression of VCAM-1 expression. Phytomedicine 2009;16 (11): 1027-32.
328. Moon MK, Lee YJ, Kim JS, Kang DG, Lee HS. Effect of caffeic acid on tumor necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells. Biol Pharm Bull 2009; 32 (8): 1371-7.
329. Kim JH, Lee BJ, Kim JH, Yu YS, Kim KW. Anti-angiogenic effect of caffeic acid on retinal neovascularization. Vasc Pharmacol 2009;51 (4): 262-7.
330. Chung MJ, Walker PA, Hogstrand C. Dietary phenolic antioxidants, caffeic acid and Trolox, protect rainbow trout gill cells from nitric oxide-induced apoptosis. Aquat Toxicol 2006; 80 (4): 321-8.
331. Pari L, Prasath A. Efficacy of caffeic acid in preventing nickel induced oxidative damage in liver of rats. Chem Biol Interact 2008;173 (2): 77-83.
332. Krakauer T. The polyphenol chlorogenic acid inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. ImmunoPharmacol Immunotoxicol 2002; 24 (1): 113-9.
333. Li SY, Chang CQ, Ma FY, Yu CL. Modulating effects of chlorogenic acid on lipids and glucose metabolism and expression of hepatic peroxisome proliferator-activated receptor-[alpha] in golden hamsters fed on high fat diet. Biomed Environ Sci 2009; 22 (2): 122-9.
334. Chang WC, Chen CH, Lee MF, Chang T, Yu YM. Chlorogenic acid attenuates adhesion molecules upregulation in IL-1beta-treated endothelial cells. Eur J Nutr 2009; 49 (5): 267-75.
335. Chao LK, Hua KF, Hsu HY, et al. Cinnamaldehyde inhibits proinflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food Chem Toxicol 2008; 46 (1): 220-31.
336. Lee HS, Kim BS, Kim MK. Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase. J Agric Food Chem 2002; 50 (26): 7700-3.
337. Liao BC, Hsieh CW, Liu YC, et al. Cinnamaldehyde inhibits the tumor necrosis factor-[alpha]-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-[kappa]B activation: Effects upon I[kappa]B and Nrf2. Toxicol Appl Pharmacol 2008; 229 (2): 161-71.
338. Siddiqui AM, Cui X, Wu R, et al. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by upregulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med 2006; 34 (7): 1874-82.
339. Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P. Curcumin protects against acute liver damage in the rat by inhibiting NF-[kappa]B, proinflammatory cytokines production and oxidative stress. Biochim Biophys Acta 2007; 1770 (6): 989-96.
340. Pan MH, Lin-Shiau SY, Lin JK. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of I[kappa]B kinase and NF[kappa]B activation in macrophages. BioChem Pharmacol 2000; 60 (11): 1665-76.
341. Kumar A, Dhawan S, Hardegen NJ, Aggarwal BB. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)- mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-[kappa]B activation. BioChem Pharmacol 1998, 55 (6): 775-83.
342. Philip S, Kundu GC. Osteopontin induces nuclear factor κBmediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways, and curcumin (diferulolyl-methane) down-regulates these pathways. J Biol Chem 2003; 278 (16): 14487-97.
343. Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signalregulated kinase activity and NF-{kappa}B activation. Carcinogenesis 2003; 24 (9): 1515-24.
344. Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 1999;18 (44): 6013-20.
345. Singh S, Aggarwal BB. Activation of transcription factor NF-B is suppressed by curcumin (diferuloylmethane). J Biol Chem 2095,270 (42): 24995-5000.
346. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa Balpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003; 101 (3): 1053-62.
347. Gupta B, Ghosh B. Curcuma longa inhibits TNF-[alpha] induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 1999; 21 (11): 745-57.
348. Balasubramanyam M, Koteswari A, Kumar R, Monickaraj S, Maheswari J, Mohan V. Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. J Biosci 2003; 28 (6): 715-21.
349. Bi XL, Yang JY, Dong YX, et al. Resveratrol inhibits nitric oxide and TNF-[alpha] production by lipopolysaccharide-activated microglia. Int Immunopharmacol 2005; 5 (1): 185-93.
350. Kennedy A, Overman A, Lapoint K, et al. Conjugated linoleic acid-mediated inflammation and insulin resistance in human adipocytes are attenuated by resveratrol. J Lipid Res 2009; 50 (2): 225-32.
351. Zhang Y, Luo Z, Ma L, Xu Q, Yang Q, Si, L. Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. Int J Mol Med 2010; 25 (5): 729-34.
352. Cheng G, Zhang X, Gao D, Jiang X, Dong W. Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci Lett 2009; 451 (2): 105-8.
353. Ge H, Zhang JF, Guo BS, et al. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma. Vasc Pharmacol 2007; 46 (2): 114-21.
354. Inoue H, Jiang XF, Katayama T, Osada S, Umesono K, Namura S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor [alpha] in mice. Neurosci. Lett 2003; 352 (3): 203-6.
355. Adhami VM, Afaq F, Ahmad N. Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia 2003; 5 (1): 74-82.
356. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-{kappa}B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000; 164 (12): 6509-19.
357. Holmes-McNary M, Baldwin AS. Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the I{{kappa}}B kinase. Cancer Res 2000; 60 (13): 3477-83.
358. Ferrero M, Bertelli A, Fulgenzi A, et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr 1998, 68 (6): 1208-14.
359. Jang DS, Kang BS, Ryu SY, Chang ILM, Min KR, Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosaninduced oxygen radical production. BioChem Pharmacol 1999; 57 (6): 705-12.
360. Gülçin I. Antioxidant properties of resveratrol: A structure-activity insight. Inno Food Sci Emer Technol 2010; 11 (1): 210-8.
361. Kang DG, Moon MK, Lee AS, Kwon TO, Kim JS, Lee HS. Cornuside suppresses cytokine-induced proinflammatory and adhesion molecules in the human umbilical vein endothelial cells. Biol Pharm Bull 2007; 30 (9): 1796-9.
362. Nawa Y, Endo J, Ohta T. The inhibitory effect of the components of Cornus officinalis on melanogenesis. J Cosmet Sci 2007; 58 (5): 505-17.
363. Andreadou I, Sigala F, Iliodromitis EK, et al. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J Mol Cell Cardiol 2007; 42 (3): 549-58.
364. Sun DI, Nizamutdinova IT, Kim YM, et al. Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression. Int Immunopharmacol 2008; 8 (9): 1272-81.
365. Fiebich BL, Lieb K, Engels S, Heinrich M. Inhibition of LPSinduced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J Neuroimmunol 2002;132 (1-2): 18-24.
366. Fukuda K, Hibiya Y, Mutoh M, et al. Inhibition by parthenolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Bio- Chem Pharmacol 2000; 60 (4): 595-600.
367. Wong HR, Menendez IY. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells. BioChem Biophys Res Commun 2099; 262 (2): 375-80.
368. Sheehan M, Wong HR, Hake PW, Malhotra V, O'Connor M, Zingarelli B. Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol 2002; 61 (5): 953-63.
369. Lopez-Franco O, Hernandez-Vargas P, Ortiz-Munoz G, et al. Parthenolide modulates the NF-{kappa}B-mediated inflammatory responses in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26 (8): 1864-70.
370. Hehner SP, Hofmann TG, Droge W, Schmitz ML. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF- {kappa}B by targeting the I{kappa}B kinase complex. J Immunol 1999; 163 (10): 5617-23.
371. Herrera F, Martin V, Rodriguez-Blanco J, García-Santos G, Antolín I, Rodriguez C. Intracellular redox state regulation by parthenolide. BioChem Biophys Res Commun 2005; 332 (2): 321-5.
372. Jin YC, Kim CW, Kim YM, et al. Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-[alpha]-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo. Eur J Pharmacol 2009; 614 (1-3): 91-7.
373. Jeon S, Son K, Kim Y, Choi Y, Kim H. Inhibition of prostaglandin and nitric oxide production in lipopolysaccharide-treated RAW264.7 cells by tanshinones from the roots of Salvia miltiorrhiza bunge. Arch Pharm Res 2008; 31 (6): 758-63.
374. Tang S, Shen XY, Huang HQ, et al. Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264.7 macrophages through inhibition of the NF-kappaB and MAPK signaling pathways. Inflammation 2010.
375. Park EJ, Zhao YZ, Kim YC, Sohn DH. Preventive effects of a purified extract isolated from Salvia miltiorrhiza enriched with tanshinone I, tanshinone IIA and cryptotanshinone on hepatocyte injury in vitro and in vivo. Food Chem Toxicol 2009; 47 (11): 2742-8.
376. Li R, Chen B, Wu W, Bao L, Li J, Qi R. Ginkgolide B suppresses intercellular adhesion molecule-1 expression via blocking nuclear factor-kappaB activation in human vascular endothelial cells stimulated by oxidized low-density lipoprotein. J Pharmacol Sci 2009; 110 (3): 362-9.
377. Fan GW, Gao XM, Wang H, et al. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Bio- Chem Mol Biol 2009; 113 (3-5): 275-80.
378. Chen TH, Hsu YT, Chen CH, Kao SH, Lee HM. Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells. Mitochondrion 2007; 7 (1-2): 101-5.
379. Il Jang S, Jin Kim H, Kim YJ, Jeong SI, You YO. Tanshinone IIA inhibits LPS-induced NF-[kappa]B activation in RAW 264.7 cells: Possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol 2006; 542 (1-3): 1-7.
380. Fang Zy, Lin R, Yuan Bx, Liu Y, Zhang H. Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet. Life Sci 2007; 81 (17-18): 1339-45.
381. Niu XL, Ichimori K, Yang X, Hirota Y, Hoshiai K, Li M, Nakazawa H. Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic Res 2000; 33 (3): 305-12.
382. Zhang WJ, Hufnagl P, Binder BR, Wojta J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost 2003; 90 (5): 904-14.
383. Luo Y, Qin Z, Hong Z, et al. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett 2004; 363 (3): 218-23.
384. Huang YL, Kou JP, Liu JH, Liu N, Yu BY. Comparison of antiinflammatory activities of ruscogenin, a major steroidal sapogenin from Radix Ophiopogon japonicus, and its succinylated derivative, RUS-2HS. Drug Dev Res 2008; 69 (4): 196-202.
385. Huang YL, Kou JP, Ma L, Song JX, Yu BY. Possible mechanism of the anti-inflammatory activity of ruscogenin: Role of intercellular adhesion molecule-1 and nuclear factor-kappa. B J Pharmacol Sci 2008; 108 (2): 198-205.
386. Bustos P, Duffau C, Pacheco C, Ulloa N. [beta]-Sitosterol modulation of monocyte-endothelial cell interaction: A comparison to female hormones. Maturitas 2008; 60 (3-4): 202-8.
387. Loizou S, Lekakis I, Chrousos GP, Moutsatsou P. beta-Sitosterol exhibits anti-inflammatory activity in human aortic endothelial cells. Mol Nutr Food Res 2010; 54 (4): 551-8.
388. Vivancos M, Moreno JJ. [beta]-Sitosterol modulates antioxidant enzyme response in RAW 264.7 macrophages. Free Radic Biol Med 2005; 39 (1): 91-7.
389. Yoon JJ, Lee YJ, Kim JS, Kang DG, Lee HS. Protective role of betulinic acid on TNF-[alpha]-induced cell adhesion molecules in vascular endothelial cells. BioChem Biophys Res Commun 2010;391 (1): 96-101.
390. Nguemfo E, Dimo T, Dongmo A, et al. Anti-oxidative and antiinflammatory activities of some isolated constituents from the stem bark of Allanblackia monticola Staner L.C (Guttiferae). Inflammopharmacology 2009; 17 (1): 37-41.
391. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000; 49 (10): 497-505.
392. Hertog MGL, Feskens EJM, Kromhout D, Hollman PCH, Katan MB. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342 (8878): 1007-11.
393. Lin MC, Tsai MJ, Wen KC. Supercritical fluid extraction of flavonoids from Scutellariae Radix. J Chromatogr A 1999; 830 (2): 387-95.
394. Wang CZ, Mehendale SR, Yuan CS. Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness. Am J Chin Med 2007; 35 (4): 543-58.
395. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365 (9468): 1415-28.
396. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE. The metabolic syndrome in australia: prevalence using four definitions. Diabetes Res Clin Pract 2007; 77 (3): 471-8.
397. Kressel G, Trunz B, Bub A, et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis 2009; 202 (1): 263-71.